Filing Flows

Filing Flows › Proto Labs (PRLB) › Guidance & outlook

Proto Labs (PRLB) guidance and outlook

Proto Labs (PRLB) raised its guidance on Oct 29, 2026: Revenue +10% to +11% for FY2026; Revenue $143M–$151M for Q4 2026; EPS $0.28–$0.36 for Q4 2026; EPS $0.46–$0.54 for Q4 2026.

Guidance and outlook

Proto Labs Revenue: guidance against what was reportedProto Labs Revenue: guidance against what was reportedguided rangereported (above / within / below)Q1 2025$126MQ2 2025$135MQ3 2025$135MQ4 2025$136MQ1 2026$139MQ2 2026$149MQ3 2026$154MQ4 2026
Met or beat 7 of 7 guided periods. Grey: the last range guided before the figures came out; dot: the reported figure.

Latest guidance

MetricPeriodRangeChange
RevenueFY2026+10% to +11%raised
RevenueQ4 2026$143M–$151Mnew
EPSQ4 2026$0.28–$0.36new
EPSQ4 2026$0.46–$0.54new

From the earnings release filed Oct 29, 2026 (8-K on EDGAR).

Proto Labs' latest quarter

Proto Labs, Q3 2026: revenue $154M (+14% year over year), operating margin 9.4%, net earnings $11.8M, operating cash flow $22.8M. The chart follows the revenue to costs, profit and cash.

Questions

Did Proto Labs raise or lower its guidance?

Proto Labs (PRLB) raised its guidance on Oct 29, 2026: Revenue +10% to +11% for FY2026; Revenue $143M–$151M for Q4 2026; EPS $0.28–$0.36 for Q4 2026; EPS $0.46–$0.54 for Q4 2026.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.